Benchmark maintains its buy rating on MSTR with a price target of $650. As of Monday, MicroStrategy purchased a further 2,530 ...

Elon Musk is being sued by the U.S. Securities and Exchange Commission, claiming he didn't disclose purchases of Twitter ...

Regenxbio's rolling BLA submission completion of RGX-121 for the treatment of patients with MPS II expected in Q1 of 2025.

The SEC sued Elon Musk, accusing the X owner of failing to properly disclose his purchases of Twitter stock in 2022.

Elon Musk cheated Twitter shareholders by waiting too long to disclose his growing stake in the company, the U.S. Securities ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

Blaize (BZAI) and BurTech Acquisition Corp announced that they expect to complete their previously announced business combination on January 12. The combined company will be named ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

In total, Musk underpaid Twitter investors by more than $150 million for his purchases of Twitter common stock during this ...

The US Securities and Exchange Commission sued Elon Musk on Tuesday for failing to properly disclose his ownership of X, then ...

SemiLEDs Corp (NASDAQ:LEDS), a $11 million market cap player in the semiconductor industry, has entered into amendments to its existing loan agreements, extending the maturity dates and providing ...

Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced that it has entered into a definitive agreement to ...